Neuberger Berman Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-8,382
| Closed | -$200K | – | 2123 |
|
|
2025
Q2 | $200K | Buy |
+8,382
| New | +$211K | ﹤0.01% | 1892 |
|
|
2022
Q2 | – | Sell |
-18,489
| Closed | -$1.41M | – | 1908 |
|
|
2022
Q1 | $1.41M | Buy |
18,489
+9,680
| +110% | +$645K | ﹤0.01% | 1272 |
|
|
2021
Q4 | $525K | Sell |
8,809
-26,840
| -75% | -$1.48M | ﹤0.01% | 1535 |
|
|
2021
Q3 | $2M | Sell |
35,649
-15,510
| -30% | -$894K | ﹤0.01% | 1170 |
|
|
2021
Q2 | $3.1M | Sell |
51,159
-7,087
| -12% | -$449K | ﹤0.01% | 1078 |
|
|
2021
Q1 | $4.08M | Buy |
58,246
+37,484
| +181% | +$2.68M | ﹤0.01% | 998 |
|
|
2020
Q4 | $1.24M | Buy |
20,762
+3,613
| +21% | +$212K | ﹤0.01% | 1206 |
|
|
2020
Q3 | $1.03M | Buy |
+17,149
| New | +$996K | ﹤0.01% | 1211 |
|
|
2017
Q2 | – | Sell |
-32,500
| Closed | -$1.48M | – | 1630 |
|
|
2017
Q1 | $1.48M | Buy |
+32,500
| New | +$1.4M | ﹤0.01% | 1069 |
|
|
2016
Q2 | – | Sell |
-21,067
| Closed | -$1.12M | – | 1572 |
|
|
2016
Q1 | $1.12M | Buy |
21,067
+6,805
| +48% | +$398K | ﹤0.01% | 1084 |
|
|
2015
Q4 | $1.09M | Sell |
14,262
-259,201
| -95% | -$14.7M | ﹤0.01% | 1110 |
|
|
2015
Q3 | $11.2M | Buy |
273,463
+155,395
| +132% | +$9.52M | 0.01% | 759 |
|
|
2015
Q2 | $8.35M | Sell |
118,068
-109,453
| -48% | -$8.62M | 0.01% | 859 |
|
|
2015
Q1 | $20.2M | Buy |
227,521
+25,994
| +13% | +$2.64M | 0.02% | 691 |
|
|
2014
Q4 | $17.9M | Sell |
201,527
-71,727
| -26% | -$6.78M | 0.02% | 696 |
|
|
2014
Q3 | $26.5M | Buy |
273,254
+109,543
| +67% | +$10.7M | 0.03% | 593 |
|
|
2014
Q2 | $15M | Buy |
163,711
+70,921
| +76% | +$5.4M | 0.01% | 732 |
|
|
2014
Q1 | $6.49M | Buy |
92,790
+37,155
| +67% | +$2.53M | 0.01% | 890 |
|
|
2013
Q4 | $3.2M | Buy |
55,635
+12,665
| +29% | +$666K | ﹤0.01% | 968 |
|
|
2013
Q3 | $2.07M | Sell |
42,970
-36,280
| -46% | -$1.32M | ﹤0.01% | 1041 |
|
|
2013
Q2 | $2.3M | Buy |
+79,250
| New | +$2.29M | ﹤0.01% | 1014 |
|
Other funds holding PCRX
DPCM
